Power Law company profile

BlueRock Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2016 Unicorn

Regenerative medicine company

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

2 investors on BlueRock Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Versant Ventures

Bayer

Global footprint

Where BlueRock Therapeutics has talent and traffic

Workforce by country

7 countries with
team presence

🇨🇦 Canada49.5%

🇺🇸 United States48.6%

🇩🇪 Germany0.8%

🇸🇦 Saudi Arabia0.3%

🇮🇳 India0.3%

Top 5 of 7 shown

Web traffic by country

27K monthly visits
across markets

🇺🇸 United States60%

🇨🇦 Canada20.4%

🇮🇳 India17%

🇩🇪 Germany3.7%

Top 4 markets shown

Patent intelligence

$2M patent portfolio · 23 active families

Estimated portfolio value

$2M

0.19% of valuation · 82.9× smaller than top peer Exelixis ($161M)

23 active patent families

Where BlueRock Therapeutics innovates Molecular biologyCell biologyBiochemistryBiomedical engineeringCell

Where BlueRock Therapeutics concentrates vs peers

Each axis is a top-10 topic across BlueRock Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about BlueRock Therapeutics

An AI-synthesized read of the highest-engagement posts about BlueRock Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BlueRock Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles